Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$356.01 - $451.55 $553,951 - $702,611
1,556 New
1,556 $669,000
Q1 2022

May 16, 2022

SELL
$254.45 - $351.06 $1.09 Million - $1.51 Million
-4,291 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$272.01 - $353.03 $1.35 Million - $1.75 Million
-4,958 Reduced 53.61%
4,291 $1.5 Million
Q4 2020

Feb 16, 2021

SELL
$248.13 - $308.36 $252,100 - $313,293
-1,016 Reduced 9.9%
9,249 $2.72 Million
Q1 2020

May 14, 2020

SELL
$108.83 - $165.23 $687,370 - $1.04 Million
-6,316 Reduced 38.09%
10,265 $1.35 Million
Q4 2019

Feb 13, 2020

SELL
$106.59 - $164.21 $2.34 Million - $3.61 Million
-22,000 Reduced 57.02%
16,581 $2.66 Million
Q2 2019

Aug 14, 2019

BUY
$115.0 - $141.58 $575,000 - $707,900
5,000 Added 14.89%
38,581 $0
Q1 2019

May 15, 2019

SELL
$98.85 - $134.59 $5.29 Million - $7.2 Million
-53,500 Reduced 61.44%
33,581 $4.19 Million
Q4 2018

Feb 14, 2019

SELL
$63.81 - $109.82 $3.15 Million - $5.41 Million
-49,300 Reduced 36.15%
87,081 $8.37 Million
Q3 2018

Nov 14, 2018

BUY
$75.5 - $96.63 $10.3 Million - $13.2 Million
136,381 New
136,381 $10.3 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.